Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts
Open Access
- 12 July 2011
- Vol. 118 (3), 797-803
- https://doi.org/10.1002/cncr.26338
Abstract
BACKGROUND: Statins are widely used cholesterol‐lowering agents that may have potential antitumor effect. Epidemiological studies on statin use and renal cell carcinoma (RCC) risk have been inconsistent. METHODS: The authors investigated the association between statin use and RCC risk in the Nurses' Health Study and Health Professionals Follow‐Up Study. In total, 80,782 women and 37,869 men were followed for 14 years and 16 years, respectively. Regular statin use was assessed at baseline and was updated biennially during follow‐up. RCC diagnosis was confirmed by medical record review. RESULTS: Two hundred seventy‐seven incident RCC cases (164 women and 113 men) were identified. Compared with no current use, the multivariate relative risks of current statin use were 0.68 (95% confidence interval, 0.46‐1.00) in women and 1.17 (95% confidence interval, 0.75‐1.82) in men. The results for ever versus never users of statins were similar. No dose‐response relation with duration of statin use and RCC risk was observed. On subgroup analyses, statin use was associated with a reduced RCC risk among women who had no history of hypertension. CONCLUSIONS: The current study indicated that statin use may be associated with a lower risk of RCC in women, although these results need to be investigated further. Cancer 2012;. © 2011 American Cancer Society.This publication has 30 references indexed in Scilit:
- Type 2 Diabetes and the Risk of Renal Cell Cancer in WomenDiabetes Care, 2011
- Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch databaseBMJ, 2010
- Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune toleranceClinical and Experimental Immunology, 2010
- Reproductive Factors and Risk of Renal Cell Cancer: The Nurses' Health StudyAmerican Journal of Epidemiology, 2009
- Contemporary Epidemiology of Renal Cell CancerThe Cancer Journal, 2008
- Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell CarcinomaClinical Cancer Research, 2008
- Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in MenGastroenterology, 2008
- Total Fluid Intake and Use of Individual Beverages and Risk of Renal Cell Cancer in Two Large CohortsCancer Epidemiology, Biomarkers & Prevention, 2006
- The Role of Statins in Cancer TherapyThe Oncologist, 2006
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002